Skip to content
DataLookout
Menu

INFER 2NCT06851130

Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Dec 31, 2025 to Dec 31, 2026
    • Eligibility criteria expanded, about 7 words
    • Enrollment closed, study ongoing
    • Site details revised
  2. Minor Start date changed from estimate of Feb 27, 2025 to Feb 25, 2025v2
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Serum ferritin
Timeframe: Study day 31

Secondary (5)

alpha(1)-acid-glycoprotein
Serum ferritin
Serum Ferritin
Hemoglobin
C-reactive protein

Arms and interventions

80 mgExperimental

Daily dose of 80 mg of iron for 1 month, with a 7-day break, then again for another month (2 months total).

160Experimental

Daily dose of 160 mg of iron for 1 month, with a 7-day break, then again for another month (2 months total).

Dietary supplements: ferrous sulfate 80 mg, ferrous sulfate 160 mg

Sites

1 site in 1 country

  • Laboratory of Nutrition and Metabolic EpigeneticsZurich, Canton of Zurich, Switzerland